Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel이스라엘의 감염 유도 면역과 백신 유도 면역이 있는 개인의 COVID-19 관련 입원율 비교Article Published on 2022-04-222022-09-11 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, 임상, 진단, [키워드] adjusted BNT162b2 booster booster vaccination confounders COVID-19 COVID-19 pandemic COVID-19 vaccine Critical delta variant dose doses Effectiveness ENhance enhancer FIVE Hospitalization Immunity incidence rate individual less population immunity predominant provide reduced subsequent vaccine dose vaccine immunity Vaccine-induced immunity were assessed [DOI] 10.1038/s41467-022-29858-5 PMC 바로가기 [Article Type] Article
Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 – COVID-NET, 14 States, March 2020-February 2022실험실에서 확인된 COVID-19로 5-11세 아동의 입원 - COVID-NET, 14개 주, 2020년 3월-2022년 2월Article Published on 2022-04-222022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, [키워드] accounted affected age all age groups analyzed authorization B.1.1.529 black cause CDC Characteristics children Committee conditions Coverage COVID-19 COVID-19 vaccine Critical cumulative diabete diabetes drug Emergency Emergency use authorization food Food and Drug Administration group had no Health highlight Hospitalization Hospitalized ICU Increasing intensive care intensive care unit Medical conditions network obesity omicron outcomes pandemic Pfizer-BioNTech Practice predominant proportion Racial rapid increase severe COVID-19 The United States United States vaccination variant of SARS-CoV-2 virus Year [DOI] 10.15585/mmwr.mm7116e1 PMC 바로가기 [Article Type] Article
Benefits of integrated screening and vaccination for infection control감염관리를 위한 통합검진 및 예방접종의 장점Article Published on 2022-04-212022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] adverse outcome base Characteristics college Community compartmental model Compliance Coverage COVID-19 infections deaths delta variant develop disease disease spread disease transmission Diseases effective Effectiveness Efficacy Frequency Hospitalization hospitalizations hypothetical infection control Infectious diseases initial Intervention Model parameter predominant reduce Reproduction number reproduction numbers Safe Screening sensitivity analysis the vaccine Transmission vaccination vaccination rate Vaccination strategies Vaccine [DOI] 10.1371/journal.pone.0267388 PMC 바로가기 [Article Type] Article
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine Research Published on 2022-04-192022-10-05 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] acute respiratory syndrome Amino acid anti-viral response Asymptomatic Bacterial cellular coronavirus Coronavirus disease 2019 COVID-19 COVID-19 patients cytokine profile dendritic cell disease Donor effective Efficacy effort elicit elicited epitope experiment Health Human humoral immune responses immune response Immunity in vivo indicated introduced negative control NTD NTD domain pathogen peptide peptide-based vaccine performed positive control predominant Protein provided Receptor binding domain Research SARS-CoV-2 SARS-CoV-2 vaccine subjects tested the Spike the vaccine Vaccine vaccine candidate Vaccines Validity volunteers [DOI] 10.1038/s41598-022-09615-w [Article Type] Research
Reproduction Number of the Omicron Variant Triples That of the Delta VariantOmicron 변이체의 복제 수는 Delta 변이체의 3배입니다.Article Published on 2022-04-152022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjust article conducted Coverage COVID-19 Critical Delta delta variant effective effort estimates Google Scholar Immune escape Measures Meta-analysis number omicron Omicron variant pandemic predominant presenting public health reproduction Reproduction number reproduction numbers SARS-CoV-2 systematic review Transmissibility Vaccine variant Web of Science [DOI] 10.3390/v14040821 PMC 바로가기 [Article Type] Article
Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements인도네시아, 아세안 및 주변 동아시아 국가에서 SARS-CoV-2의 게놈 프로파일링: 기능, 도전 및 성과Article Published on 2022-04-082022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] achievement ASEAN Biology biology of SARS-CoV-2 Biotechnology center challenge Clinical research collaboration country COVID-19 COVID-19 pandemic defined delta variant Delta variants East Asian Epidemiology facilitated Frequency Genome genomic Genomic surveillance GISAID highest Indonesia Innovation Interaction Japan Lineage Metadata Mutation N439K Nanopore NICCRAT ONT Open Access outbreak Oxford Phylogenetic analysis predominant Profiling SARS- CoV-2 SARS-CoV-2 SARS-CoV-2 virus Sequencing Singapore spike gene Surveillance team technology training Travel unique university variant variants variants of concern virus virus transmission WGS whole-genome sequencing [DOI] 10.3390/v14040778 PMC 바로가기 [Article Type] Article
Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan일본에서 델타형 우려변이 출현 전후 아동의 코로나19 임상적 특징 및 결과 비교Observational Study Published on 2022-04-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] age children children with COVID-19 Clinical characteristics clinical feature Clinical features conducted coronavirus disease Coronavirus disease 2019 COVID-19 Delta delta variant Delta variant of concern. Delta VOC died disease Enrollment ERAS extracorporeal membrane oxygenation information intensive care intensive care unit Japan mechanical ventilation median observational study outcome Patient patient age Pediatric patient Pediatric patients predominant proportion Registered registry remained required Respiratory Coronavirus retrospective study period the timing two group two groups underlying disease underlying diseases variant VoC with COVID-19 [DOI] 10.1016/j.jiac.2022.01.009 PMC 바로가기 [Article Type] Observational Study
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults – VISION Network, 10 States, December 2021-March 2022Ad.26.COV2.S(Janssen [Johnson & Johnson]) 백신 1회 투여 후 동종 및 이종 COVID-19 추가 용량의 효과 COVID-19 관련 응급실 및 성인의 긴급 치료 만남 및 입원에 대한 백신 용량 - VISION Network, 10 미국, 2021년 12월-2022년 3월Article Published on 2022-04-012022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, [키워드] addition Adenovirus Against booster booster dose booster vaccination Care CDC circulating clinical trial comparable COVID-19 COVID-19 vaccine Department dose doses Effectiveness eligible Emergency encounter examined Guillain-barrè syndrome Heterologous heterologous mRNA vaccine homologous Hospitalization hospitalizations janssen laboratory-confirmed mRNA mRNA vaccine mRNA vaccines network Neutralizing antibody response omicron predominant provided receipt receive risk Serious Adverse Event Serious Adverse Events syndrome thrombocytopenia thrombosis time interval vaccination Vaccination strategy Vaccine vaccine dose variant [DOI] 10.15585/mmwr.mm7113e2 PMC 바로가기 [Article Type] Article
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India인도의 SARS-CoV-2 백신 돌발 감염에 대한 우려의 변종Article Published on 2022-04-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] AZD1222 B.1.1.7 B.1.617.2 Breakthrough infection breakthrough infections COVID-19 Efficacy genomic Genomic analysis India isolate isolates Lineage predominant responsible SARS-CoV-2 SARS-CoV-2 vaccine Surveillance vaccination Vaccine vaccine breakthrough infections Vaccines variants variants of concern [DOI] 10.1002/jmv.27461 PMC 바로가기 [Article Type] Article
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy남부 이탈리아 요양원의 2020년 감염 클러스터에서 SARS-CoV-2의 전체 게놈 분석Article Published on 2022-04-012022-09-12 Journal: Infection, genetics and evolution : journal of mol [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Analysis analyzed association B.1 lineage Calabria carried clade clinical parameter Cluster COVID-19 D614G Evolution Frequency Genome Haplotype haplotypes help hotspot indicated Infection initial investigated IQ-TREE Italy NC_045512.2 next generation sequencing NGS nursing home outbreak Pandemics Patient patients predominant responsible SARS-CoV-2 SARS-CoV-2 viral sequence single nucleotide variation SNV SNVs South Spread Swab UTR viral genome viral spread viral strain Viral transmission [DOI] 10.1016/j.meegid.2022.105253 PMC 바로가기 [Article Type] Article